These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 7799065

  • 1. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ.
    J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin-receptor imaging in lymphoma.
    Goldsmith SJ, Macapinlac HA, O'Brien JP.
    Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor-based imaging in malignant lymphomas.
    O'Brien JP.
    J Nucl Med; 1995 Jan; 36(1):19-20. PubMed ID: 7799074
    [No Abstract] [Full Text] [Related]

  • 4. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
    Lipp RW, Schnedl WJ, Aglas F, Ranner G, Beham-Schmid C, Leb G, Sill H.
    Acta Med Austriaca; 1999 Jan; 26(3):105-8. PubMed ID: 10520379
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography.
    Bares R, Galonska P, Dempke W, Handt S, Büll U, Osieka R.
    Horm Metab Res Suppl; 1993 Jan; 27():56-8. PubMed ID: 8330873
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
    Reubi JC, Waser B, van Hagen M, Lamberts SW, Krenning EP, Gebbers JO, Laissue JA.
    Int J Cancer; 1992 Apr 01; 50(6):895-900. PubMed ID: 1348240
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptor scintigraphy in the staging of lymphomas.
    Ivancević V, Wörmann B, Nauck C, Sandrock D, Munz DL, Hiddemann W, Emrich D.
    Leuk Lymphoma; 1997 Jun 01; 26(1-2):107-14. PubMed ID: 9250794
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
    Lugtenburg PJ, Löwenberg B, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, van Putten WL, Krenning EP.
    J Nucl Med; 2001 Feb 01; 42(2):222-9. PubMed ID: 11216520
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
    Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ.
    J Nucl Med; 1992 May 01; 33(5):652-8. PubMed ID: 1349039
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor imaging.
    Kwekkeboom DJ, Krenning EP.
    Semin Nucl Med; 2002 Apr 01; 32(2):84-91. PubMed ID: 11965603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 111In-octreotide scintigraphy in oncology.
    Krenning EP, Kwekkeboom DJ, Reubi JC, van Hagen PM, van Eijck CH, Oei HY, Lamberts SW.
    Digestion; 1993 Apr 01; 54 Suppl 1():84-7. PubMed ID: 8359573
    [Abstract] [Full Text] [Related]

  • 14. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
    Li S, Kurtaran A, Li M, Traub-Weidinger T, Kienast O, Schima W, Angelberger P, Virgolini I, Raderer M, Dudczak R.
    Eur J Nucl Med Mol Imaging; 2003 Aug 01; 30(8):1087-95. PubMed ID: 12768334
    [Abstract] [Full Text] [Related]

  • 15. The relevance of somatostatin receptor expression in malignant lymphomas.
    van den Anker-Lugtenburg PJ, Löwenberg B, Lamberts SW, Krenning EP.
    Metabolism; 1996 Aug 01; 45(8 Suppl 1):96-7. PubMed ID: 8769395
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin receptor scintigraphy in cutaneous malignant lymphomas.
    van den Anker-Lugtenburg PJ, Heule F, Vanhagen PM, van Joost T, Oei HY, Löwenberg B, Krenning EP.
    J Am Acad Dermatol; 1996 Jun 01; 34(6):985-93. PubMed ID: 8647992
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
    Haldemann AR, Rösler H, Barth A, Waser B, Geiger L, Godoy N, Markwalder RV, Seiler RW, Sulzer M, Reubi JC.
    J Nucl Med; 1995 Mar 01; 36(3):403-10. PubMed ID: 7884502
    [Abstract] [Full Text] [Related]

  • 18. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
    Sarda L, Duet M, Zini JM, Berolatti B, Benelhadj S, Tobelem G, Mundler O.
    Eur J Nucl Med; 1995 Oct 01; 22(10):1105-9. PubMed ID: 8542892
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
    de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M.
    Eur J Nucl Med; 1994 Nov 01; 21(11):1191-7. PubMed ID: 7859770
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.